The APOE gene and cognitive function in non-demented and Alzheimer's disease patients

被引:2
|
作者
Payton, Antony [1 ]
机构
[1] Univ Manchester, Ctr Integrated Genom Med Res, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England
关键词
APOE; genetics; polymorphism; Alzheimer's disease; ageing; memory; cognition;
D O I
10.1017/S0959259809990268
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
This review discusses the role that the APOE gene plays in cognitive dysfunction both in demented and non-demented elderly people. The increasing problem of cognitive impairment in developed countries makes finding new and effective treatments a research priority. Understanding the biological basis of this impairment is therefore paramount. APOE has received much attention in the field of cognitive genetics due to it being a major susceptibility gene for Alzheimer's disease, which itself is characterized by a rapid and irreversible loss in memory function. Over the past 14 years this has generated a considerable number of publications that have produced conflicting findings, making it difficult for the reader to interpret whether the APOE gene regulates cognition or not. This review attempts to summarize the mass of information on this gene in relation to cognition, by weighting the pros and cons of the methodologies used, and offers suggestions for future study designs.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 50 条
  • [21] Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson's Disease Patients
    Aiello, Edoardo Nicolo
    D'Iorio, Alfonsina
    Solca, Federica
    Torre, Silvia
    Colombo, Eleonora
    Maranzano, Alessio
    De Lorenzo, Alberto
    Patisso, Valerio
    Treddenti, Mauro
    Morelli, Claudia
    Doretti, Alberto
    Maderna, Luca
    Verde, Federico
    Ferrucci, Roberta
    Barbieri, Sergio
    Ruggiero, Fabiana
    Priori, Alberto
    Silani, Vincenzo
    Ticozzi, Nicola
    Santangelo, Gabriella
    Ciammola, Andrea
    Poletti, Barbara
    [J]. NEURODEGENERATIVE DISEASES, 2023, 22 (3-4) : 159 - 163
  • [22] Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease
    Leverenz, James B.
    Watson, G. Stennis
    Shofer, Jane
    Zabetian, Cyrus P.
    Zhang, Jing
    Montine, Thomas J.
    [J]. PARKINSONISM & RELATED DISORDERS, 2011, 17 (01) : 61 - 64
  • [23] Alzheimer's Disease-Type Pathology in the Non-Demented Elderly
    Nelson, Peter
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (05): : 524 - 524
  • [24] Cognitive decline in a group of longitudinally followed non-demented patients with Parkinson's disease
    Zhelev, Y. E.
    Raycheva, M. R.
    Petrova, M. I.
    Traykov, L. D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 138 - 139
  • [25] Cognitive dysfunction in non-demented Parkinson's disease patients: Controlled and automatic behavior
    Koerts, Janneke
    Leenders, Klaus L.
    Brouwer, Wiebo H.
    [J]. CORTEX, 2009, 45 (08) : 922 - 929
  • [26] Apathy and executive function in non-demented Parkinson's disease
    Kellison, I
    Krish-Darrow, L.
    Lopez, M.
    Crucian, G.
    Do, T.
    Fernandez, H.
    Okun, M. S.
    Bowers, D.
    [J]. CLINICAL NEUROPSYCHOLOGIST, 2006, 20 (03) : 597 - 597
  • [27] APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains
    Joseph O. Ojo
    Jon M. Reed
    Gogce Crynen
    Prashanthi Vallabhaneni
    James Evans
    Benjamin Shackleton
    Maximillian Eisenbaum
    Charis Ringland
    Anastasia Edsell
    Michael Mullan
    Fiona Crawford
    Corbin Bachmeier
    [J]. Molecular Brain, 14
  • [28] APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains
    Ojo, Joseph O.
    Reed, Jon M.
    Crynen, Gogce
    Vallabhaneni, Prashanthi
    Evans, James
    Shackleton, Benjamin
    Eisenbaum, Maximillian
    Ringland, Charis
    Edsell, Anastasia
    Mullan, Michael
    Crawford, Fiona
    Bachmeier, Corbin
    [J]. MOLECULAR BRAIN, 2021, 14 (01)
  • [29] Cognitive alterations in non-demented CADASIL patients
    Taillia, H
    Chabriat, H
    Kurtz, A
    Verin, M
    Levy, C
    Vahedi, K
    Tournier-Lasserve, E
    Bousser, MG
    [J]. CEREBROVASCULAR DISEASES, 1998, 8 (02) : 97 - 101
  • [30] Subjective cognitive decline reflects recent cognitive change in non-demented patients with Parkinson's disease
    Hong, J. Y.
    Lee, Y.
    Sunwoo, M.
    Sohn, Y.
    Lee, P. H.
    [J]. MOVEMENT DISORDERS, 2017, 32